Top Markets
Coin of the day
Niki BioSolutions, Inc. Niki BioSolutions, Inc.

Niki BioSolutions, Inc.

NIKI
Rank in Stocks #38980
Niki BioSolutions is a biopharmaceutical company that resulted from the merger... Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Share Price
$8.69
Market Cap
$707.69K
Change (1 day)
3.82%
Change (1 year)
-94.05%
Country
US
Trade Niki BioSolutions, Inc. (NIKI)

Category

Operating Margin for Niki BioSolutions, Inc. (NIKI)
Operating Margin as of 2026 TTM: 0.00%
According to Niki BioSolutions, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Niki BioSolutions, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.